SAN DIEGO, Oct. 22, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today announced that Shintaro Asako, Chief Financial Officer of MediciNova, will present a company overview at the 7th Annual BIO Investor Forum Conference on Wednesday, October 29, 2008, at 2:15 p.m. Pacific time (5:15 p.m. Eastern time). The conference is being held at the Palace Hotel in San Francisco, California.
